Correlation Between Lixte Biotechnology and XOMA

Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and XOMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and XOMA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lixte Biotechnology Holdings and XOMA Corporation, you can compare the effects of market volatilities on Lixte Biotechnology and XOMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of XOMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and XOMA.

Diversification Opportunities for Lixte Biotechnology and XOMA

-0.46

Correlation Coefficient

Lixte Biotechnology  XOMA

Very good diversification

The 3 months correlation between Lixte and XOMA is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and XOMA Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XOMA and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with XOMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XOMA has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and XOMA go up and down completely randomly.

Pair Corralation between Lixte Biotechnology and XOMA

Given the investment horizon of 90 days Lixte Biotechnology Holdings is expected to under-perform the XOMA. In addition to that, Lixte Biotechnology is 23.81 times more volatile than XOMA Corporation. It trades about -0.09 of its total potential returns per unit of risk. XOMA Corporation is currently generating about 0.07 per unit of volatility. If you would invest  2,516  in XOMA Corporation on December 27, 2024 and sell it today you would earn a total of  27.00  from holding XOMA Corporation or generate 1.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Lixte Biotechnology Holdings  vs.  XOMA Corp.

Lixte Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lixte Biotechnology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

XOMA

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in XOMA Corporation are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, XOMA is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Lixte Biotechnology and XOMA

The main advantage of trading using opposite Lixte Biotechnology and XOMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, XOMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XOMA will offset losses from the drop in XOMA's long position.

The idea behind Lixte Biotechnology Holdings and XOMA Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.